TABLE 4.
Critical events in each period.
| Critical events | 1st | n | 2nd | n | 3rd | n | 4th | n | 5th | n | 6th | n |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All critical events | 25 (49) | 51 | 24 (50) | 48 | 40 (57) | 70 | 22 (52) | 42 | 50 (60) | 82 | 57 (63) | 91 |
| RDI < 85%, n (%) | 10 (20) | 51 | 6 (13) | 48 | 19 (27) | 70 | 10 (24) | 42 | 28 (34) | 82 | 42 (46) | 91 |
| Time to the first visit ≥3 months, n (%) a | ||||||||||||
| Symptom | 12 (34) | 35 | 19 (49) | 39 | 21 (41) | 51 | 15 (48) | 31 | 19 (33) | 58 | 23 (38) | 61 |
| Screening | 1 (0.8) | 13 | 0 (0) | 7 | 1 (6) | 17 | 0 (0) | 9 | 0 (0) | 15 | 1 (5) | 20 |
| Postponement ≥15 days, n (%) | 8 (2) | 51 | 4 (8) | 48 | 6 (9) | 70 | 2 (5) | 42 | 12 (15) | 82 | 14 (15) | 91 |
| Postponement ≥2 cycles, n (%) | 9 (18) | 51 | 9 (19) | 48 | 19 (27) | 70 | 3 (7) | 42 | 22 (27) | 82 | 16 (18) | 91 |
| Start of Adj ≥91 days after surgery | 0 (0) | 25 | 2 (4) | 22 | 0 (0) | 28 | 0 (0) | 23 | 4 (10) | 41 | 6 (14) | 42 |
Abbreviations: Adj, adjuvant chemotherapy; RDI, relative dose intensity.
a
Excluding patients who were diagnosed with breast cancer while under follow‐up for other cancers in our hospital.